OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Anti-Infective Therapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	95
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	85
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	66
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	65
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	65
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	62
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	54
Visceral leishmaniasis elimination in India: progress and the road ahead	50
Neonatal ocular prophylaxis in the United States: is it still necessary?	43
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	39
Challenges in preserving antibiotic effectiveness: time for a novel approach	38
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	35
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	35
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	34
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	32
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	29
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	29
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	28
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	26
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	25
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	24
Treatment of vaginitis caused by non-albicans Candida species	24